FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016183775> ?p ?o ?g. }

• W2016183775 endingPage "155" @default.
• W2016183775 startingPage "149" @default.
• W2016183775 abstract "Sixty-five patients who were primary or secondary refractory to melphalan/prednisone or other type of chemotherapy, or relapsed within 6 months after high dose chemotherapy with stem cell support, were given thalidomide at a dose of 200 mg/d escalating to 800 mg. The patients were followed for a median of 2 years and 22 weeks. Response was evaluated according to M-protein reduction combined with improvement of haemoglobin (Hb) concentration, renal function and pain. Altogether, 14% of patients had a minor response, 14% partial response and 6% complete response. Median survival was 12 months and 29% were alive at last contact. Decline of M protein started early and a minimum 25% reduction of M protein was detected in 14 of 20 responders (70%) after 3 weeks, and in 20 of 22 responders (91%) after 5 weeks of treatment. Reduction of M protein continued for 3 months and further decline was observed in only four patients. The Hb concentration showed a different time course, with a significant increase after 3 months and further increases continued for up to 12 months. Blood concentration levels of thalidomide from 40 patients were used to evaluate the pharmacokinetics of the drug. Rate of absorption, rate of elimination, volume of distribution, clearance and elimination half-life were calculated to be 0.200/h, 0.140/h, 0.886 l/kg, 0.126 l/h/kg and 4.98 h respectively. We found no relationship between thalidomide concentration and effect after 12 weeks." @default.
• W2016183775 created "2016-06-24" @default.
• W2016183775 creator A5003689547 @default.
• W2016183775 creator A5022052738 @default.
• W2016183775 creator A5027908456 @default.
• W2016183775 creator A5028102234 @default.
• W2016183775 creator A5029832651 @default.
• W2016183775 creator A5033275967 @default.
• W2016183775 creator A5040294556 @default.
• W2016183775 creator A5051008993 @default.
• W2016183775 creator A5068471072 @default.
• W2016183775 creator A5077837562 @default.
• W2016183775 creator A5081919656 @default.
• W2016183775 date "2004-03-08" @default.
• W2016183775 modified "2023-10-18" @default.
• W2016183775 title "Early response predicts thalidomide efficiency in patients with advanced multiple myeloma*" @default.
• W2016183775 cites W1779162675 @default.
• W2016183775 cites W1947168884 @default.
• W2016183775 cites W1966156828 @default.
• W2016183775 cites W1987023520 @default.
• W2016183775 cites W1997317029 @default.
• W2016183775 cites W2018076602 @default.
• W2016183775 cites W2081446774 @default.
• W2016183775 cites W2093070779 @default.
• W2016183775 cites W2093544430 @default.
• W2016183775 cites W2104613102 @default.
• W2016183775 cites W2136113007 @default.
• W2016183775 cites W2136226957 @default.
• W2016183775 cites W2167736322 @default.
• W2016183775 cites W2316160054 @default.
• W2016183775 doi "https://doi.org/10.1111/j.1365-2141.2004.04879.x" @default.
• W2016183775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15059136" @default.
• W2016183775 hasPublicationYear "2004" @default.
• W2016183775 type Work @default.
• W2016183775 sameAs 2016183775 @default.
• W2016183775 citedByCount "32" @default.
• W2016183775 countsByYear W20161837752012 @default.
• W2016183775 countsByYear W20161837752013 @default.
• W2016183775 countsByYear W20161837752014 @default.
• W2016183775 countsByYear W20161837752015 @default.
• W2016183775 countsByYear W20161837752017 @default.
• W2016183775 countsByYear W20161837752018 @default.
• W2016183775 countsByYear W20161837752019 @default.
• W2016183775 countsByYear W20161837752022 @default.
• W2016183775 crossrefType "journal-article" @default.
• W2016183775 hasAuthorship W2016183775A5003689547 @default.
• W2016183775 hasAuthorship W2016183775A5022052738 @default.
• W2016183775 hasAuthorship W2016183775A5027908456 @default.
• W2016183775 hasAuthorship W2016183775A5028102234 @default.
• W2016183775 hasAuthorship W2016183775A5029832651 @default.
• W2016183775 hasAuthorship W2016183775A5033275967 @default.
• W2016183775 hasAuthorship W2016183775A5040294556 @default.
• W2016183775 hasAuthorship W2016183775A5051008993 @default.
• W2016183775 hasAuthorship W2016183775A5068471072 @default.
• W2016183775 hasAuthorship W2016183775A5077837562 @default.
• W2016183775 hasAuthorship W2016183775A5081919656 @default.
• W2016183775 hasBestOaLocation W20161837751 @default.
• W2016183775 hasConcept C112705442 @default.
• W2016183775 hasConcept C121332964 @default.
• W2016183775 hasConcept C126322002 @default.
• W2016183775 hasConcept C126894567 @default.
• W2016183775 hasConcept C139254425 @default.
• W2016183775 hasConcept C141071460 @default.
• W2016183775 hasConcept C142424586 @default.
• W2016183775 hasConcept C2776364478 @default.
• W2016183775 hasConcept C2776694085 @default.
• W2016183775 hasConcept C2778684742 @default.
• W2016183775 hasConcept C2778720950 @default.
• W2016183775 hasConcept C2779609412 @default.
• W2016183775 hasConcept C71924100 @default.
• W2016183775 hasConcept C87355193 @default.
• W2016183775 hasConcept C90924648 @default.
• W2016183775 hasConceptScore W2016183775C112705442 @default.
• W2016183775 hasConceptScore W2016183775C121332964 @default.
• W2016183775 hasConceptScore W2016183775C126322002 @default.
• W2016183775 hasConceptScore W2016183775C126894567 @default.
• W2016183775 hasConceptScore W2016183775C139254425 @default.
• W2016183775 hasConceptScore W2016183775C141071460 @default.
• W2016183775 hasConceptScore W2016183775C142424586 @default.
• W2016183775 hasConceptScore W2016183775C2776364478 @default.
• W2016183775 hasConceptScore W2016183775C2776694085 @default.
• W2016183775 hasConceptScore W2016183775C2778684742 @default.
• W2016183775 hasConceptScore W2016183775C2778720950 @default.
• W2016183775 hasConceptScore W2016183775C2779609412 @default.
• W2016183775 hasConceptScore W2016183775C71924100 @default.
• W2016183775 hasConceptScore W2016183775C87355193 @default.
• W2016183775 hasConceptScore W2016183775C90924648 @default.
• W2016183775 hasIssue "2" @default.
• W2016183775 hasLocation W20161837751 @default.
• W2016183775 hasLocation W20161837752 @default.
• W2016183775 hasOpenAccess W2016183775 @default.
• W2016183775 hasPrimaryLocation W20161837751 @default.
• W2016183775 hasRelatedWork W1976805847 @default.
• W2016183775 hasRelatedWork W2009299738 @default.
• W2016183775 hasRelatedWork W2073254795 @default.
• W2016183775 hasRelatedWork W2088444650 @default.
• W2016183775 hasRelatedWork W2141779216 @default.
• W2016183775 hasRelatedWork W2273737858 @default.

• next